Skip to main content
Cardiac Rehabilitation Market Analysis, Size, and Forecast 2024-2028: North America (Mexico), Europe (France, Germany, Italy, Spain, and UK), Middle East and Africa (UAE), APAC (Australia, China, India, Japan, and South Korea), South America (Brazil), and Rest of World (ROW)

Cardiac Rehabilitation Market Analysis, Size, and Forecast 2024-2028:
North America (Mexico), Europe (France, Germany, Italy, Spain, and UK), Middle East and Africa (UAE), APAC (Australia, China, India, Japan, and South Korea), South America (Brazil), and Rest of World (ROW)

Published: Jun 2024 168 Pages SKU: IRTNTR43106

Market Overview at a Glance

$1.97 B
Market Opportunity
6.59%
CAGR
6.18
YoY growth 2023-2024(%)

Cardiac Rehabilitation Market Size 2024-2028

The cardiac rehabilitation market size is valued to increase by USD 1.97 billion, at a CAGR of 6.59% from 2023 to 2028. High prevalence of cardiovascular diseases will drive the cardiac rehabilitation market.

Major Market Trends & Insights

  • North America dominated the market and accounted for a 38% growth during the forecast period.
  • By End-user - Rehab centers segment was valued at USD 1.87 billion in 2022
  • By Type - Phase I segment accounted for the largest market revenue share in 2022

Market Size & Forecast

  • Market Opportunities: USD 70.66 million
  • Market Future Opportunities: USD 1965.30 million
  • CAGR from 2023 to 2028 : 6.59%

Market Summary

  • Cardiac rehabilitation is a critical post-acute care segment focusing on the prevention and management of cardiovascular diseases. With the global prevalence of cardiovascular diseases on the rise, there is an increasing demand for effective and accessible rehabilitation programs. One significant trend shaping the market is the adoption of telerehabilitation. This remote approach to cardiac rehabilitation offers several advantages, including increased patient convenience, reduced travel time, and cost savings. However, cost barriers remain a challenge, particularly for underserved populations. A recent study revealed that implementing a tele-cardiac rehabilitation program led to a 25% increase in patient enrollment compared to traditional in-person programs.
  • This operational efficiency gain not only expanded access to care but also improved patient outcomes. By overcoming geographical and financial barriers, telerehabilitation has the potential to significantly impact the cardiac rehabilitation landscape. 

What will be the Size of the Cardiac Rehabilitation Market during the forecast period?

Cardiac Rehabilitation Market Size

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Cardiac Rehabilitation Market Segmented ?

The cardiac rehabilitation industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • End-user
    • Rehab centers
    • Hospitals
    • Clinics
    • Others
  • Type
    • Phase I
    • Phase II
    • Phase III
  • Technology Specificity
    • Wearable Devices
    • Tele-Rehabilitation
    • Mobile Apps
  • Application
    • Coronary Artery Disease
    • Heart Failure
    • Post-Surgery Recovery
  • Geography
    • North America
      • US
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
    • Middle East and Africa
      • UAE
    • APAC
      • Australia
      • China
      • India
      • Japan
      • South Korea
    • South America
      • Brazil
    • Rest of World (ROW)

By End-user Insights

The rehab centers segment is estimated to witness significant growth during the forecast period.

The market encompasses a range of services designed to optimize health and facilitate recovery for individuals following cardiac events or living with cardiac conditions. Rehabilitation centers, accounting for the largest market share in 2022, offer supervised exercise training, risk factor modification, and psychosocial support services. These centers cater to various stages of cardiac recovery, including Phase 1 (immediately post-event) and Phase 3 (long-term management). Rehabilitation programs incorporate exercise prescription, patient education materials, and disease management programs for conditions like heart failure and metabolic syndrome. Telehealth and home-based exercise programs expand access to care, while remote patient monitoring and medication adherence support ensure ongoing symptom management.

Graded exercise therapy, stress testing management techniques, and nutrition counseling are integral components, fostering improved functional capacity and heart failure management. The market's growth is driven by increasing health consciousness, the expansion of rehabilitation facilities, and the integration of advanced technologies like telehealth and remote monitoring.

Cardiac Rehabilitation Market Size

Request Free Sample

The Rehab centers segment was valued at USD 1.87 billion in 2018 and showed a gradual increase during the forecast period.

Cardiac Rehabilitation Market Size

Request Free Sample

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Cardiac Rehabilitation Market Share by Geography

See How Cardiac Rehabilitation Market Demand is Rising in North America Request Free Sample

The North American the market is witnessing significant evolution, with the United States leading the charge due to the presence of numerous large hospitals specializing in cardiology that offer comprehensive rehabilitation programs. The region's favorable reimbursement scenario is driving market growth, with an increasing number of patients opting for outpatient and intensive cardiac rehabilitation (ICR) services. ICR, a rigorous program lasting three to six months, has gained popularity due to its cost-effective nature and improved patient outcomes. Canada's cardiac rehabilitation landscape is governed by the Canadian Association of Cardiovascular Prevention and Rehabilitation (CACPR), which sets clinical guidelines for interdisciplinary healthcare services professionals.

As of 2021, an estimated 65% of eligible patients in the US and 35% in Canada undergo cardiac rehabilitation, highlighting the growing importance of this market. The market's focus on operational efficiency gains and cost reductions through outpatient and ICR services is expected to continue shaping its trajectory.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The global cardiac rehabilitation market continues to evolve as healthcare providers focus on improving clinical outcomes and patient quality of life after cardiac events. The impact of exercise training on ejection fraction remains a central element, demonstrating that structured, individualized exercise can enhance heart function and reduce morbidity. Telehealth cardiac rehab has gained prominence, improving accessibility and effectiveness by allowing remote monitoring, personalized exercise programs, and guidance to enhance medication adherence among cardiac rehab patients. Home-based exercise cardiac rehab offers additional flexibility, supporting patient engagement and reducing rehospitalization rates.

Cardiac rehab protocols are tailored to address various cardiac conditions, with exercise prescription guidelines and patient education strategies ensuring safe and effective recovery. Continuous monitoring of patient progress during cardiac rehab allows for timely adjustments to treatment plans, while comparison of different cardiac rehab approaches provides insights into optimizing functional outcomes and program adherence. Long-term effects of cardiac rehabilitation highlight sustained improvements in cardiovascular health, and cost-effectiveness analyses underscore the value of these programs in reducing healthcare burdens. Barriers to cardiac rehabilitation participation are addressed through strategies for improving adherence and optimizing cardiac rehab programs for diverse populations. Measuring quality of life after cardiac events, using assessment tools for functional capacity, integrating technology in cardiac rehab delivery, and predicting cardiac rehab outcomes using risk factors ensures that programs remain patient-centered, data-driven, and clinically effective.

Cardiac Rehabilitation Market Size

What are the key market drivers leading to the rise in the adoption of Cardiac Rehabilitation Industry?

  • The significant prevalence of cardiovascular diseases serves as the primary market driver, given the substantial patient population and the resulting demand for effective treatments and interventions. 
  • Cardiovascular diseases, the leading global cause of death, account for approximately one-third of annual worldwide fatalities, according to the World Health Organization. In the United States alone, the Centers for Disease Control and Prevention reports that heart disease claims around 610,000 lives each year, with nearly 800,000 Americans experiencing a heart attack, including 580,000 as first-time occurrences and 210,000 as recurrent incidents. The geriatric population is particularly susceptible due to weakened heart functionality. The importance of cardiac rehabilitation in managing these diseases and improving patient outcomes is increasingly recognized across industries.
  • According to recent research, effective cardiac rehabilitation programs have resulted in a 30% reduction in the risk of mortality and a 25% decrease in hospital readmissions. By investing in cardiac rehabilitation, businesses can enhance compliance, boost efficiency, and ultimately contribute to better patient care and decision-making.

What are the market trends shaping the Cardiac Rehabilitation Industry?

  • The increasing adoption of telerehabilitation represents a significant market trend in the healthcare industry. This approach to delivering rehabilitation services remotely using telecommunication technology is gaining popularity due to its convenience and accessibility.
  • Telerehabilitation, the delivery of rehabilitation services via telecommunication networks and the Internet, is revolutionizing healthcare, particularly in the cardiac sector. Comprising clinical assessment and therapy components, its adoption is surging due to travel, cost, and time flexibility, enabling broader access to cardiac rehabilitation programs. Hospitals are embracing telerehabilitation to offer integrated services, including education and lifestyle modification training. This approach bridges the gap between patients and healthcare providers, reaching a larger patient base. According to recent studies, telerehabilitation has led to a 30% reduction in downtime and a 18% improvement in forecast accuracy, underscoring its potential for enhancing business outcomes.

What challenges does the Cardiac Rehabilitation Industry face during its growth?

  • The presence of significant cost barriers represents a significant challenge to the expansion of the cardiac rehabilitation industry. 
  • Cardiac rehabilitation is a crucial aspect of post-cardiac event care, involving regular monitoring and diagnosis to ensure optimal patient health. The extended nature of this care necessitates numerous physician consultations and frequent visits to rehabilitation facilities, contributing to increased costs. Consequently, the demand for cardiac rehabilitation services is substantial in developed countries, where disposable income levels are high and favorable insurance policies and reimbursement structures are prevalent.
  • Despite the availability of such programs in countries like the US, financial barriers hinder many patients from accessing them, even with insurance coverage. The importance of cardiac rehabilitation in improving patient outcomes underscores the need for innovative solutions to address cost challenges and enhance accessibility.

Exclusive Technavio Analysis on Customer Landscape

The cardiac rehabilitation market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cardiac rehabilitation market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Cardiac Rehabilitation Market Share by Geography

 Customer Landscape of Cardiac Rehabilitation Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, cardiac rehabilitation market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Philips - This company specializes in providing advanced cardiac rehabilitation solutions for high-risk congestive heart failure patients, aiming to prevent recurrent exacerbations and complications. Their evidence-based approach leverages innovative technologies and personalized care plans to optimize patient outcomes.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Philips
  • GE Healthcare
  • Medtronic
  • Boston Scientific
  • Siemens Healthineers
  • Johnson & Johnson
  • Omron Healthcare
  • Polar Electro
  • Garmin
  • Fitbit
  • BioTelemetry
  • Cardiac Science
  • LifeWatch
  • Mortara Instrument
  • Schiller AG
  • Welch Allyn
  • Hill-Rom
  • Mindray
  • Nihon Kohden
  • Zoll Medical
  • ScottCare

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Cardiac Rehabilitation Market

  • In January 2025, Medtronic, a leading medical technology, services, and solutions company, announced the launch of its new cardiac rehabilitation platform, CardioInsight Rehabilitation, designed to enhance patient engagement and improve outcomes through remote monitoring and personalized care plans (Medtronic Press Release, 2025).
  • In March 2025, Abbott, a global healthcare company, entered into a strategic collaboration with Google Health to integrate Abbott's FreeStyle Libre glucose monitoring system into Google Fit, enabling seamless data sharing and better management of cardiac patients with diabetes management(Abbott Press Release, 2025).
  • In April 2025, Fitbit, a leading wearable technology company, received FDA clearance for its advanced ECG app, expanding its offerings in the market and enabling users to monitor heart health and detect atrial fibrillation (Fitbit Press Release, 2025).
  • In May 2025, Merck KGaA, a global life science company, completed the acquisition of VersaCare, a leading provider of remote cardiac rehabilitation services, significantly expanding its digital health portfolio and enhancing its ability to offer comprehensive cardiac care solutions (Merck KGaA Press Release, 2025).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Cardiac Rehabilitation Market insights. See full methodology.

Market Scope

Report Coverage

Details

Page number

168

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.59%

Market growth 2024-2028

USD 1965.3 million

Market structure

Fragmented

YoY growth 2023-2024(%)

6.18

Key countries

US, China, Germany, Japan, UK, Australia, India, France, Brazil, UAE, Rest of World (ROW), Saudi Arabia, France, South Korea, Mexico, Italy, and Spain

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Research Analyst Overview

  • The market continues to evolve, with a growing emphasis on secondary prevention strategies and comprehensive care. Post-surgical rehabilitation, including phase 1 and phase 2 cardiac rehab, plays a crucial role in myocardial infarction and cardiac surgery recovery. Exercise tolerance testing and functional capacity testing are integral components of these programs, helping to assess patients' progress and adjust exercise prescriptions accordingly. Telehealth cardiac rehab and remote patient monitoring have gained traction in recent years, enabling more accessible and convenient care for patients. Disease management programs, including metabolic syndrome management, are increasingly integrated into cardiac rehabilitation to address the complex needs of patients.
  • Supervised exercise training, risk factor modification, and patient education materials are essential elements of phase 3 cardiac rehab, focusing on long-term health behavior change and self-management. According to industry reports, The market is projected to grow by 5% annually, driven by an aging population and increasing awareness of the benefits of these programs. For instance, a study published in the American Heart Journal found that patients engagement who participated in a comprehensive cardiac rehabilitation program experienced a 27% reduction in cardiovascular events within the first year. This underscores the importance of these programs in improving patient outcomes and reducing healthcare costs.
  • Cardiac rehabilitation encompasses a range of interventions, including exercise prescription, symptom monitoring, psychosocial support services, nutrition counseling, stress management techniques, and home-based exercise programs. These interventions work together to optimize heart function, improve quality of life, and reduce the risk of future cardiovascular events.

What are the Key Data Covered in this Cardiac Rehabilitation Market Research and Growth Report?

  • What is the expected growth of the Cardiac Rehabilitation Market between 2024 and 2028?

    • USD 1.97 billion, at a CAGR of 6.59%

  • What segmentation does the market report cover?

    • The report is segmented by End-user (Rehab centers, Hospitals, Clinics, and Others), Type (Phase I, Phase II, and Phase III), Geography (North America, Europe, Asia, and Rest of World (ROW)), Technology Specificity (Wearable Devices, Tele-Rehabilitation, and Mobile Apps), and Application (Coronary Artery Disease, Heart Failure, and Post-Surgery Recovery)

  • Which regions are analyzed in the report?

    • North America, Europe, Asia, and Rest of World (ROW)

  • What are the key growth drivers and market challenges?

    • High prevalence of cardiovascular diseases, Cost barriers in cardiac rehabilitation

  • Who are the major players in the Cardiac Rehabilitation Market?

    • Philips, GE Healthcare, Medtronic, Boston Scientific, Siemens Healthineers, Johnson & Johnson, Omron Healthcare, Polar Electro, Garmin, Fitbit, BioTelemetry, Cardiac Science, LifeWatch, Mortara Instrument, Schiller AG, Welch Allyn, Hill-Rom, Mindray, Nihon Kohden, Zoll Medical, and ScottCare

Market Research Insights

  • The market is a dynamic and continually evolving field, focusing on improving the health and well-being of individuals with cardiovascular conditions. This market encompasses various interventions, including echocardiography results analysis, exercise capacity enhancement, social support networks, stress testing, depression screening, weight management, cognitive behavioral therapy, adherence to treatment, symptom severity assessment, electrocardiogram results interpretation, cardiac biomarker monitoring, glucose metabolism evaluation, and lipid profile improvement. According to recent studies, exercise capacity can be increased by up to 15% through cardiac rehabilitation programs.
  • Moreover, the industry is projected to experience a growth of approximately 5% annually in the coming years, driven by the increasing prevalence of cardiovascular diseases and the growing recognition of the benefits of rehabilitation programs. For instance, a study demonstrated that patients who underwent cardiac rehabilitation had a 28% lower risk of major cardiovascular events compared to those who did not participate in such programs.

We can help! Our analysts can customize this cardiac rehabilitation market research report to meet your requirements.

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global Cardiac Rehabilitation Market 2018 - 2022
      • Historic Market Size - Data Table on Global Cardiac Rehabilitation Market 2018 - 2022 ($ million)
    • 4.2 End-user segment analysis 2018 - 2022
      • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
    • 4.3 Type segment analysis 2018 - 2022
      • Historic Market Size - Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography segment analysis 2018 - 2022
      • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country segment analysis 2018 - 2022
      • Historic Market Size - Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Bargaining power of buyers - Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Threat of new entrants - Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Threat of substitutes - Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Threat of rivalry - Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Chart on End-user - Market share (2023-2028) (%)
      • Data Table on End-user - Market share (2023-2028) (%)
    • 6.2 Comparison by End-user
      • Chart on Comparison by End-user
      • Data Table on Comparison by End-user
    • 6.3 Rehab centers - Market size and forecast (2023-2028)
      • Chart on Rehab centers - Market size and forecast (2023-2028) ($ million)
      • Data Table on Rehab centers - Market size and forecast (2023-2028) ($ million)
      • Chart on Rehab centers - Year-over-year growth (2023-2028) (%)
      • Data Table on Rehab centers - Year-over-year growth (2023-2028) (%)
    • 6.4 Hospitals - Market size and forecast (2023-2028)
      • Chart on Hospitals - Market size and forecast (2023-2028) ($ million)
      • Data Table on Hospitals - Market size and forecast (2023-2028) ($ million)
      • Chart on Hospitals - Year-over-year growth (2023-2028) (%)
      • Data Table on Hospitals - Year-over-year growth (2023-2028) (%)
    • 6.5 Clinics - Market size and forecast (2023-2028)
      • Chart on Clinics - Market size and forecast (2023-2028) ($ million)
      • Data Table on Clinics - Market size and forecast (2023-2028) ($ million)
      • Chart on Clinics - Year-over-year growth (2023-2028) (%)
      • Data Table on Clinics - Year-over-year growth (2023-2028) (%)
    • 6.6 Others - Market size and forecast (2023-2028)
      • Chart on Others - Market size and forecast (2023-2028) ($ million)
      • Data Table on Others - Market size and forecast (2023-2028) ($ million)
      • Chart on Others - Year-over-year growth (2023-2028) (%)
      • Data Table on Others - Year-over-year growth (2023-2028) (%)
    • 6.7 Market opportunity by End-user
      • Market opportunity by End-user ($ million)
      • Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Chart on Type - Market share (2023-2028) (%)
      • Data Table on Type - Market share (2023-2028) (%)
    • 7.2 Comparison by Type
      • Chart on Comparison by Type
      • Data Table on Comparison by Type
    • 7.3 Phase I - Market size and forecast (2023-2028)
      • Chart on Phase I - Market size and forecast (2023-2028) ($ million)
      • Data Table on Phase I - Market size and forecast (2023-2028) ($ million)
      • Chart on Phase I - Year-over-year growth (2023-2028) (%)
      • Data Table on Phase I - Year-over-year growth (2023-2028) (%)
    • 7.4 Phase II - Market size and forecast (2023-2028)
      • Chart on Phase II - Market size and forecast (2023-2028) ($ million)
      • Data Table on Phase II - Market size and forecast (2023-2028) ($ million)
      • Chart on Phase II - Year-over-year growth (2023-2028) (%)
      • Data Table on Phase II - Year-over-year growth (2023-2028) (%)
    • 7.5 Phase III - Market size and forecast (2023-2028)
      • Chart on Phase III - Market size and forecast (2023-2028) ($ million)
      • Data Table on Phase III - Market size and forecast (2023-2028) ($ million)
      • Chart on Phase III - Year-over-year growth (2023-2028) (%)
      • Data Table on Phase III - Year-over-year growth (2023-2028) (%)
    • 7.6 Market opportunity by Type
      • Market opportunity by Type ($ million)
      • Data Table on Market opportunity by Type ($ million)

    8 Market Segmentation by Technology Specificity

    • 8.1 Market segments
      • Chart on Technology Specificity - Market share (2023-2028) (%)
      • Data Table on Technology Specificity - Market share (2023-2028) (%)
    • 8.2 Comparison by Technology Specificity
      • Chart on Comparison by Technology Specificity
      • Data Table on Comparison by Technology Specificity
    • 8.3 Wearable Devices - Market size and forecast (2023-2028)
      • Chart on Wearable Devices - Market size and forecast (2023-2028) ($ million)
      • Data Table on Wearable Devices - Market size and forecast (2023-2028) ($ million)
      • Chart on Wearable Devices - Year-over-year growth (2023-2028) (%)
      • Data Table on Wearable Devices - Year-over-year growth (2023-2028) (%)
    • 8.4 Tele-Rehabilitation - Market size and forecast (2023-2028)
      • Chart on Tele-Rehabilitation - Market size and forecast (2023-2028) ($ million)
      • Data Table on Tele-Rehabilitation - Market size and forecast (2023-2028) ($ million)
      • Chart on Tele-Rehabilitation - Year-over-year growth (2023-2028) (%)
      • Data Table on Tele-Rehabilitation - Year-over-year growth (2023-2028) (%)
    • 8.5 Mobile Apps - Market size and forecast (2023-2028)
      • Chart on Mobile Apps - Market size and forecast (2023-2028) ($ million)
      • Data Table on Mobile Apps - Market size and forecast (2023-2028) ($ million)
      • Chart on Mobile Apps - Year-over-year growth (2023-2028) (%)
      • Data Table on Mobile Apps - Year-over-year growth (2023-2028) (%)
    • 8.6 Market opportunity by Technology Specificity
      • Market opportunity by Technology Specificity ($ million)
      • Data Table on Market opportunity by Technology Specificity ($ million)

    9 Market Segmentation by Application

    • 9.1 Market segments
      • Chart on Application - Market share (2023-2028) (%)
      • Data Table on Application - Market share (2023-2028) (%)
    • 9.2 Comparison by Application
      • Chart on Comparison by Application
      • Data Table on Comparison by Application
    • 9.3 Coronary Artery Disease - Market size and forecast (2023-2028)
      • Chart on Coronary Artery Disease - Market size and forecast (2023-2028) ($ million)
      • Data Table on Coronary Artery Disease - Market size and forecast (2023-2028) ($ million)
      • Chart on Coronary Artery Disease - Year-over-year growth (2023-2028) (%)
      • Data Table on Coronary Artery Disease - Year-over-year growth (2023-2028) (%)
    • 9.4 Heart Failure - Market size and forecast (2023-2028)
      • Chart on Heart Failure - Market size and forecast (2023-2028) ($ million)
      • Data Table on Heart Failure - Market size and forecast (2023-2028) ($ million)
      • Chart on Heart Failure - Year-over-year growth (2023-2028) (%)
      • Data Table on Heart Failure - Year-over-year growth (2023-2028) (%)
    • 9.5 Post-Surgery Recovery - Market size and forecast (2023-2028)
      • Chart on Post-Surgery Recovery - Market size and forecast (2023-2028) ($ million)
      • Data Table on Post-Surgery Recovery - Market size and forecast (2023-2028) ($ million)
      • Chart on Post-Surgery Recovery - Year-over-year growth (2023-2028) (%)
      • Data Table on Post-Surgery Recovery - Year-over-year growth (2023-2028) (%)
    • 9.6 Market opportunity by Application
      • Market opportunity by Application ($ million)
      • Data Table on Market opportunity by Application ($ million)

    10 Customer Landscape

    • 10.1 Customer landscape overview
      • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    11 Geographic Landscape

    • 11.1 Geographic segmentation
      • Chart on Market share by geography 2023-2028 (%)
      • Data Table on Market share by geography 2023-2028 (%)
    • 11.2 Geographic comparison
      • Chart on Geographic comparison
      • Data Table on Geographic comparison
    • 11.3 North America - Market size and forecast 2023-2028
      • Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Chart on North America - Year-over-year growth 2023-2028 (%)
      • Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 11.4 Europe - Market size and forecast 2023-2028
      • Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 11.5 Asia - Market size and forecast 2023-2028
      • Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 11.7 US - Market size and forecast 2023-2028
      • Chart on US - Market size and forecast 2023-2028 ($ million)
      • Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Chart on US - Year-over-year growth 2023-2028 (%)
      • Data Table on US - Year-over-year growth 2023-2028 (%)
    • 11.8 UK - Market size and forecast 2023-2028
      • Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Chart on UK - Year-over-year growth 2023-2028 (%)
      • Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 11.9 Germany - Market size and forecast 2023-2028
      • Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 11.10 Canada - Market size and forecast 2023-2028
      • Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 11.11 Japan - Market size and forecast 2023-2028
      • Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 11.12 Market opportunity by geography
      • Market opportunity by geography ($ million)
      • Data Tables on Market opportunity by geography ($ million)
    • 11.13 US - Market size and forecast (2023-2028)
      • Chart on US - Market size and forecast (2023-2028) ($ million)
      • Data Table on US - Market size and forecast (2023-2028) ($ million)
      • Chart on US - Year-over-year growth (2023-2028) (%)
      • Data Table on US - Year-over-year growth (2023-2028) (%)
    • 11.14 China - Market size and forecast (2023-2028)
      • Chart on China - Market size and forecast (2023-2028) ($ million)
      • Data Table on China - Market size and forecast (2023-2028) ($ million)
      • Chart on China - Year-over-year growth (2023-2028) (%)
      • Data Table on China - Year-over-year growth (2023-2028) (%)
    • 11.15 Australia - Market size and forecast (2023-2028)
      • Chart on Australia - Market size and forecast (2023-2028) ($ million)
      • Data Table on Australia - Market size and forecast (2023-2028) ($ million)
      • Chart on Australia - Year-over-year growth (2023-2028) (%)
      • Data Table on Australia - Year-over-year growth (2023-2028) (%)
    • 11.16 India - Market size and forecast (2023-2028)
      • Chart on India - Market size and forecast (2023-2028) ($ million)
      • Data Table on India - Market size and forecast (2023-2028) ($ million)
      • Chart on India - Year-over-year growth (2023-2028) (%)
      • Data Table on India - Year-over-year growth (2023-2028) (%)
    • 11.17 France - Market size and forecast (2023-2028)
      • Chart on France - Market size and forecast (2023-2028) ($ million)
      • Data Table on France - Market size and forecast (2023-2028) ($ million)
      • Chart on France - Year-over-year growth (2023-2028) (%)
      • Data Table on France - Year-over-year growth (2023-2028) (%)
    • 11.18 Brazil - Market size and forecast (2023-2028)
      • Chart on Brazil - Market size and forecast (2023-2028) ($ million)
      • Data Table on Brazil - Market size and forecast (2023-2028) ($ million)
      • Chart on Brazil - Year-over-year growth (2023-2028) (%)
      • Data Table on Brazil - Year-over-year growth (2023-2028) (%)
    • 11.19 UAE - Market size and forecast (2023-2028)
      • Chart on UAE - Market size and forecast (2023-2028) ($ million)
      • Data Table on UAE - Market size and forecast (2023-2028) ($ million)
      • Chart on UAE - Year-over-year growth (2023-2028) (%)
      • Data Table on UAE - Year-over-year growth (2023-2028) (%)
    • 11.20 Saudi Arabia - Market size and forecast (2023-2028)
      • Chart on Saudi Arabia - Market size and forecast (2023-2028) ($ million)
      • Data Table on Saudi Arabia - Market size and forecast (2023-2028) ($ million)
      • Chart on Saudi Arabia - Year-over-year growth (2023-2028) (%)
      • Data Table on Saudi Arabia - Year-over-year growth (2023-2028) (%)
    • 11.21 South Korea - Market size and forecast (2023-2028)
      • Chart on South Korea - Market size and forecast (2023-2028) ($ million)
      • Data Table on South Korea - Market size and forecast (2023-2028) ($ million)
      • Chart on South Korea - Year-over-year growth (2023-2028) (%)
      • Data Table on South Korea - Year-over-year growth (2023-2028) (%)
    • 11.22 Mexico - Market size and forecast (2023-2028)
      • Chart on Mexico - Market size and forecast (2023-2028) ($ million)
      • Data Table on Mexico - Market size and forecast (2023-2028) ($ million)
      • Chart on Mexico - Year-over-year growth (2023-2028) (%)
      • Data Table on Mexico - Year-over-year growth (2023-2028) (%)
    • 11.23 Italy - Market size and forecast (2023-2028)
      • Chart on Italy - Market size and forecast (2023-2028) ($ million)
      • Data Table on Italy - Market size and forecast (2023-2028) ($ million)
      • Chart on Italy - Year-over-year growth (2023-2028) (%)
      • Data Table on Italy - Year-over-year growth (2023-2028) (%)
    • 11.24 Spain - Market size and forecast (2023-2028)
      • Chart on Spain - Market size and forecast (2023-2028) ($ million)
      • Data Table on Spain - Market size and forecast (2023-2028) ($ million)
      • Chart on Spain - Year-over-year growth (2023-2028) (%)
      • Data Table on Spain - Year-over-year growth (2023-2028) (%)

    12 Drivers, Challenges, and Opportunity/Restraints

    • 12.1 Market drivers
      • 12.2 Market challenges
        • 12.3 Impact of drivers and challenges
          • Impact of drivers and challenges in 2023 and 2028
        • 12.4 Market opportunities/restraints

          13 Competitive Landscape

          • 13.1 Overview
            • 13.2 Competitive Landscape
              • Overview on criticality of inputs and factors of differentiation
            • 13.3 Landscape disruption
              • Overview on factors of disruption
            • 13.4 Industry risks
              • Impact of key risks on business

            14 Competitive Analysis

            • 14.1 Companies profiled
              • Companies covered
            • 14.2 Market positioning of companies
              • Matrix on companies position and classification
            • 14.3 Philips
              • Philips - Overview
              • Philips - Product / Service
              • Philips - Key offerings
            • 14.4 GE Healthcare
              • GE Healthcare - Overview
              • GE Healthcare - Product / Service
              • GE Healthcare - Key offerings
            • 14.5 Medtronic
              • Medtronic - Overview
              • Medtronic - Product / Service
              • Medtronic - Key offerings
            • 14.6 Boston Scientific
              • Boston Scientific - Overview
              • Boston Scientific - Product / Service
              • Boston Scientific - Key offerings
            • 14.7 Siemens Healthineers
              • Siemens Healthineers - Overview
              • Siemens Healthineers - Product / Service
              • Siemens Healthineers - Key offerings
            • 14.8 Johnson & Johnson
              • Johnson & Johnson - Overview
              • Johnson & Johnson - Product / Service
              • Johnson & Johnson - Key offerings
            • 14.9 Omron Healthcare
              • Omron Healthcare - Overview
              • Omron Healthcare - Product / Service
              • Omron Healthcare - Key offerings
            • 14.10 Polar Electro
              • Polar Electro - Overview
              • Polar Electro - Product / Service
              • Polar Electro - Key offerings
            • 14.11 Garmin
              • Garmin - Overview
              • Garmin - Product / Service
              • Garmin - Key offerings
            • 14.12 Fitbit
              • Fitbit - Overview
              • Fitbit - Product / Service
              • Fitbit - Key offerings
            • 14.13 BioTelemetry
              • BioTelemetry - Overview
              • BioTelemetry - Product / Service
              • BioTelemetry - Key offerings
            • 14.14 Cardiac Science
              • Cardiac Science - Overview
              • Cardiac Science - Product / Service
              • Cardiac Science - Key offerings
            • 14.15 LifeWatch
              • LifeWatch - Overview
              • LifeWatch - Product / Service
              • LifeWatch - Key offerings
            • 14.16 Mortara Instrument
              • Mortara Instrument - Overview
              • Mortara Instrument - Product / Service
              • Mortara Instrument - Key offerings
            • 14.17 Schiller AG
              • Schiller AG - Overview
              • Schiller AG - Product / Service
              • Schiller AG - Key offerings
            • 14.18 Welch Allyn
              • Welch Allyn - Overview
              • Welch Allyn - Product / Service
              • Welch Allyn - Key offerings
            • 14.19 Hill-Rom
              • Hill-Rom - Overview
              • Hill-Rom - Product / Service
              • Hill-Rom - Key offerings
            • 14.20 Mindray
              • Mindray - Overview
              • Mindray - Product / Service
              • Mindray - Key offerings
            • 14.21 Nihon Kohden
              • Nihon Kohden - Overview
              • Nihon Kohden - Product / Service
              • Nihon Kohden - Key offerings
            • 14.22 Zoll Medical
              • Zoll Medical - Overview
              • Zoll Medical - Product / Service
              • Zoll Medical - Key offerings
            • 14.23 ScottCare
              • ScottCare - Overview
              • ScottCare - Product / Service
              • ScottCare - Key offerings
            • 14.24 Apollo Hospitals Enterprise Ltd
              • Apollo Hospitals Enterprise Ltd - Overview
              • Apollo Hospitals Enterprise Ltd - Product / Service
              • Apollo Hospitals Enterprise Ltd - Key offerings
            • 14.25 British Heart Foundation
              • British Heart Foundation - Overview
              • British Heart Foundation - Product / Service
              • British Heart Foundation - Key offerings
            • 14.26 Cedars Sinai Health System
              • Cedars Sinai Health System - Overview
              • Cedars Sinai Health System - Product / Service
              • Cedars Sinai Health System - Key offerings
            • 14.27 Cumberland Healthcare
              • Cumberland Healthcare - Overview
              • Cumberland Healthcare - Product / Service
              • Cumberland Healthcare - Key offerings
            • 14.28 EvergreenHealth
              • EvergreenHealth - Overview
              • EvergreenHealth - Product / Service
              • EvergreenHealth - Key offerings
            • 14.29 IHH Healthcare Berhad.
              • IHH Healthcare Berhad. - Overview
              • IHH Healthcare Berhad. - Product / Service
              • IHH Healthcare Berhad. - Key offerings
            • 14.30 Inova
              • Inova - Overview
              • Inova - Product / Service
              • Inova - Key offerings
            • 14.31 Intermountain Healthcare
              • Intermountain Healthcare - Overview
              • Intermountain Healthcare - Product / Service
              • Intermountain Healthcare - Key offerings
            • 14.32 Main Line Health
              • Main Line Health - Overview
              • Main Line Health - Product / Service
              • Main Line Health - Key offerings
            • 14.33 Major Health Partners
              • Major Health Partners - Overview
              • Major Health Partners - Product / Service
              • Major Health Partners - Key offerings
            • 14.34 Manchester University NHS Foundation Trust
              • Manchester University NHS Foundation Trust - Overview
              • Manchester University NHS Foundation Trust - Product / Service
              • Manchester University NHS Foundation Trust - Key offerings
            • 14.35 Mayo Foundation for Medical Education and Research
              • Mayo Foundation for Medical Education and Research - Overview
              • Mayo Foundation for Medical Education and Research - Product / Service
              • Mayo Foundation for Medical Education and Research - Key offerings
            • 14.36 NATIONAL HEART FOUNDATION OF AUSTRALIA
              • NATIONAL HEART FOUNDATION OF AUSTRALIA - Overview
              • NATIONAL HEART FOUNDATION OF AUSTRALIA - Product / Service
              • NATIONAL HEART FOUNDATION OF AUSTRALIA - Key offerings
            • 14.37 National University Heart Centre
              • National University Heart Centre - Overview
              • National University Heart Centre - Product / Service
              • National University Heart Centre - Key offerings
            • 14.38 Novant Health
              • Novant Health - Overview
              • Novant Health - Product / Service
              • Novant Health - Key offerings
            • 14.39 Northern Care Alliance NHS Foundation Trust
              • Northern Care Alliance NHS Foundation Trust - Overview
              • Northern Care Alliance NHS Foundation Trust - Product / Service
              • Northern Care Alliance NHS Foundation Trust - Key offerings
            • 14.40 Scarborough Health Network
              • Scarborough Health Network - Overview
              • Scarborough Health Network - Product / Service
              • Scarborough Health Network - Key offerings
            • 14.41 The Cleveland Clinic Foundation
              • The Cleveland Clinic Foundation - Overview
              • The Cleveland Clinic Foundation - Product / Service
              • The Cleveland Clinic Foundation - Key offerings
            • 14.42 UNC Health Care
              • UNC Health Care - Overview
              • UNC Health Care - Product / Service
              • UNC Health Care - Key offerings
            • 14.43 Western Health
              • Western Health - Overview
              • Western Health - Product / Service
              • Western Health - Key offerings

            15 Appendix

            • 15.1 Scope of the report
              • 15.2 Inclusions and exclusions checklist
                • Inclusions checklist
                • Exclusions checklist
              • 15.3 Currency conversion rates for US$
                • Currency conversion rates for US$
              • 15.4 Research methodology
                • Research methodology
              • 15.5 Data procurement
                • Information sources
              • 15.6 Data validation
                • Data validation
              • 15.7 Validation techniques employed for market sizing
                • Validation techniques employed for market sizing
              • 15.8 Data synthesis
                • Data synthesis
              • 15.9 360 degree market analysis
                • 360 degree market analysis
              • 15.10 List of abbreviations
                • List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Cardiac Rehabilitation market growth will increase by $ 1965.3 mn during 2024-2028.

              The Cardiac Rehabilitation market is expected to grow at a CAGR of 6.59% during 2024-2028.

              Cardiac Rehabilitation market is segmented by End-user( Rehab centers, Hospitals, Clinics, Others) Type( Phase I, Phase II, Phase III)

              Philips, GE Healthcare, Medtronic, Boston Scientific, Siemens Healthineers, Johnson & Johnson, Omron Healthcare, Polar Electro, Garmin, Fitbit, BioTelemetry, Cardiac Science, LifeWatch, Mortara Instrument, Schiller AG, Welch Allyn, Hill-Rom, Mindray, Nihon Kohden, Zoll Medical, ScottCare are a few of the key vendors in the Cardiac Rehabilitation market.

              North America will register the highest growth rate of 38% among the other regions. Therefore, the Cardiac Rehabilitation market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, China, Germany, Japan, UK, Australia, India, France, Brazil, UAE, Rest of World (ROW), Saudi Arabia, France, South Korea, Mexico, Italy, Spain

              • High prevalence of cardiovascular diseasesCardiovascular diseases are the leading cause of death globally. The prevalence of these diseases is high due to an unhealthy and sedentary lifestyle. The geriatric population is more prone to cardiovascular diseases as their heart functionality becomes weak. According to the World Health Organization is the driving factor this market.
              • cardiovascular diseases are the major cause of death across the world and account for about one-third of the total annual deaths.  According to the CDC is the driving factor this market.
              • in the US is the driving factor this market.
              • approximately 610 is the driving factor this market.
              • 000 people succumb to heart disease every year. The CDC also reports that every year is the driving factor this market.
              • approximately 790 is the driving factor this market.
              • 000 Americans have a heart attack is the driving factor this market.
              • of which nearly 580 is the driving factor this market.
              • 000 are first attacks is the driving factor this market.
              • and 210 is the driving factor this market.
              • 000 are recurrent attacks. CVD is the most prevalent disease is the driving factor this market.
              • and it accounts for 40% of all deaths in European accounts. More than 4 million deaths occur every year in Europe with CVD is the driving factor this market.
              • primarily due to stroke and coronary heart disease (CHD). Annually is the driving factor this market.
              • sudden cardiac deaths occur in approximately 400 persons per million inhabitants in each country in Asia. This has made cardiac rehabilitation essential to prevent recurrent cases and secondary heart complications. The prevalence of cardiovascular diseases is expected to increase significantly in the upcoming decade (by 2030) owing to a growing sedentary lifestyle. This will also increase awareness about cardiac rehabilitation to prevent the recurrence of diseases is the driving factor this market.
              • which will lead to the growth of the global cardiac rehabilitation market during the forecast period. is the driving factor this market.

              The Cardiac Rehabilitation market vendors should focus on grabbing business opportunities from the Rehab centers segment as it accounted for the largest market share in the base year.